Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative rare disease that affects motor neurons in the brain, brainstem, and spinal cord, resulting in progressive weakness and atrophy of voluntary skeletal muscles. Although much has been achieved in understanding the disease p...

Descripción completa

Detalles Bibliográficos
Autores principales: Albanese, Alberto, Ludolph, Albert Christian, McDermott, Christopher J., Corcia, Philippe, Van Damme, Philip, Van den Berg, Leonard H., Hardiman, Orla, Rinaldi, Gilberto, Vanacore, Nicola, Dickie, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552801/
https://www.ncbi.nlm.nih.gov/pubmed/36237618
http://dx.doi.org/10.3389/fneur.2022.1009113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552801/
https://www.ncbi.nlm.nih.gov/pubmed/36237618
http://dx.doi.org/10.3389/fneur.2022.1009113

Ejemplares similares